drugset / Trial / NCT00313716

Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury

NCT00313716

RandomizedFactorialTriple-blindTreatment

Summary

The purpose of this study is to determine the effect of early administration of recombinant human erythropoietin on long-term neurological outcome after severe traumatic brain injury.

Timeline

Start
2006-04
Primary completion
2013-03
Completion
2013-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator epoetin alfa Protein / enzyme biologic 500 iu/kg Intravenous